Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.

Günther, Gunar; Heyckendorf, Jan; Zellweger, Jean Pierre; Reimann, Maja; Claassens, Mareli; Chesov, Dumitru; van Leth, Frank (2021). Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future. Respiration, 100(9), pp. 843-852. Karger 10.1159/000516392

[img] Text
G_nther_Defining_Outcomes_of_Tuberculosis.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (280kB)

Untreated active tuberculosis (TB) has a very high long-term mortality. Treatment of TB reduces mortality dramatically and should maximize cure, preventing ongoing transmission and TB sequelae. However, predicting the risk of failure and relapse is crucial for the management of individual patients and for the evaluation of effectiveness of programs. Various outcome definitions for drug-sensitive and drug-resistant TB were developed, implemented, and endorsed since introduction of TB chemotherapy by the World Health Organization (WHO), mostly based on culture and smear results. They should be applicable for individual patient care, surveillance, and research. Definitions with focus on program evaluation differ from definitions to evaluate the efficacy and effectiveness of regimens. Lack of sputum production at the later stage of treatment reduces the easy applicability of current definitions. Definitions of failure and cure are sometimes difficult to apply. Alternative approaches suggest culture positivity at 6 months or more of treatment as an indicator for failure. New definitions for cure including a relapse-free period posttreatment and reduced number of culture and smear results are considered. Increasing variation and individualization of treatment and its duration urgently require new approaches using pathogen- or host-specific biomarkers, which indicate risk of failure and define cure. Such biomarkers are under evaluation but still far from translation in clinical routine practice.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Günther, Gunar

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0025-7931

Publisher:

Karger

Language:

English

Submitter:

Heidi Lobsiger

Date Deposited:

08 Jun 2021 08:45

Last Modified:

05 Dec 2022 15:51

Publisher DOI:

10.1159/000516392

PubMed ID:

34058739

Uncontrolled Keywords:

Definition Outcome Treatment outcome Tuberculosis

BORIS DOI:

10.48350/156614

URI:

https://boris.unibe.ch/id/eprint/156614

Actions (login required)

Edit item Edit item
Provide Feedback